학술논문

A Young Patient Presenting with Dilated Cardiomyopathy and Renal Infarction during Treatment with Isotretinoin: Mere Coincidence or Serious Side Effect of a Drug Commonly Used in Adolescence?
Document Type
Article
Source
Diagnostics (2075-4418). May2023, Vol. 13 Issue 9, p1543. 4p.
Subject
*DILATED cardiomyopathy
*CARDIAC magnetic resonance imaging
*ISOTRETINOIN
*HEART failure
*INFARCTION
*IMPLANTABLE cardioverter-defibrillators
Language
ISSN
2075-4418
Abstract
Highlights: What are the main findings? We presented a case of new onset dilated cardiomyopathy (DCM) with renal infarction in a young man on a treatment with high-dose isotretinoin. Possible known causes of DCM using a complete cardiac imaging assessment, genetic testing, and laboratory analysis have been ruled out. What is the implication of the main finding? The possible association of DCM with isotretinoin assumption is, to the authors' opinion, deserving of further investigations. Isotretinoin or 13-cis-retinoic acid (RA) is one of the most effective and widely used drugs for the treatment of severe acne vulgaris. Despite being deemed safe, no definite consensus has been reached on the cardiovascular risk of RA derivatives. We report a case of heart failure due to dilated cardiomyopathy (DCM) and concomitant renal infarction occurring after 5 months of isotretinoin use in a previously healthy 18-year-old male. The patient, with a history of acne vulgaris, presented to our emergency department with left iliac fossa pain and effort dyspnea. A trans-thoracic echocardiogram showed DCM and severely reduced left ventricle ejection fraction (LVEF: 29%). During hospitalization, a total body computed tomography (CT) showed an ischemic lesion in the left kidney. Ischemic, autoimmune, infective, and heritable causes of DCM were ruled out. Cardiac magnetic resonance (CMR) evidenced LV circumferential mid-wall late gadolinium enhancement. Heart failure therapy was promptly started and up-titrated, but only poor LVEF improvement was detected overtime. Our case aims to raise awareness on rare life-threatening cardiovascular events possibly associated with isotretinoin use. To the best of our knowledge, this is the first described case of renal thromboembolism and severe DCM leading to implantable cardioverter-defibrillator (ICD) implantation occurring during isotretinoin treatment. [ABSTRACT FROM AUTHOR]